MyoPro Approved in Australia by National Disability Insurance Scheme
First reimbursement leads to greater access for patients BOSTON (February 6, 2023) ─ Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced that for the first time, the National Disability Insurance Scheme (NDIS) in Australia approved a MyoPro […]
Myomo Appoints Yitzchak Jacobovitz to its Board of Directors
BOSTON (January 30, 2023) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Yitzchak Jacobovitz as a Class II director effective January 27, 2023, to serve until the 2025 annual meeting […]
Myomo Announces Closing of $6.5 Million Upsized Public Offering
BOSTON, January 17, 2023 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the closing of its previously announced “best efforts” public offering of 20,000,000 shares of common stock (or common stock equivalents in […]
Myomo Announces Pricing of $6.5 Million Upsized Public Offering
BOSTON, January 12, 2023 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the pricing of its “best efforts” public offering of 20,000,000 shares of common stock (or common stock equivalents in lieu thereof) […]
Myomo Announces Initiative to Reduce Cash Burn
Undertakes a reduction in force to enhance efficiency in its direct billing channel BOSTON, January 10, 2023 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced a reduction in force for the purpose of […]
Myomo Provides Update on Progress to Obtain Medicare Part B Reimbursement for MyoPro
Company to begin submitting claims after meeting with DME MAC medical directors in 2023 BOSTON (December 7, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported progress and next steps in the process to obtain […]
Ruling by German Social Court Supports MyoPro Reimbursement by Nation’s Statutory Health Insurance System
Prospective MyoPro patient wins case against DAK, Germany’s third-largest health insurer BOSTON (December 5, 2022) ─ Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that in an appeal before the Berlin-Brandenburg Regional Social Court (L […]
Myomo Reports Third Quarter 2022 Financial Results Featuring Strong Authorizations and Orders and Record Backlog
Third quarter revenue of $4.0 million, up 8% sequentially 130 authorizations and orders results in a record-high backlog of 184 units Conference call begins at 4:30 p.m. Eastern time today BOSTON (November 10, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from […]
Myomo to Report Third Quarter Financial Results on November 10, 2022
BOSTON (November 3, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the three and nine months ended September 30, 2022 on November 10, 2022, after the […]
Myomo To Present at the MicroCap Rodeo Presents The Windy City Roundup 2022
BOSTON (October 5, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, Myomo’s chairman and chief executive officer, will present at the Microcap Rodeo presents The Windy City Roundup 2022 conference, […]